Reduced Kir4.1 expression and/or activity is associated with CNS pathologies such as epilepsy, Alzheimer’s disease, amyotrophic lateral sclerosis, spinocerebellar ataxia, and pain [24,25,26,27,28,29]. Here, KCNJ10 is linked to early-onset autosomal dominant Alzheimer disease.